These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 24709221)

  • 21. Paclitaxel repackaged in an albumin-stabilized nanoparticle: handy or just a dandy?
    Sparreboom A; Baker SD; Verweij J
    J Clin Oncol; 2005 Nov; 23(31):7765-7. PubMed ID: 16258080
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro &in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction.
    Xiong XY; Guo L; Gong YC; Li ZL; Li YP; Liu ZY; Zhou M
    Eur J Pharm Sci; 2012 Aug; 46(5):537-44. PubMed ID: 22538053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel.
    Petrelli F; Borgonovo K; Barni S
    Expert Opin Pharmacother; 2010 Jun; 11(8):1413-32. PubMed ID: 20446855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.
    Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M
    J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of disulfide core-crosslinked pluronic nanoparticles as an effective anticancer-drug-delivery system.
    Abdullah-Al-Nahain ; Lee H; Lee YS; Lee KD; Park SY
    Macromol Biosci; 2011 Sep; 11(9):1264-71. PubMed ID: 21717576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and characterization of a novel polydepsipeptide contained tri-block copolymer (mPEG-PLLA-PMMD) as self-assembly micelle delivery system for paclitaxel.
    Zhao Y; Li J; Yu H; Wang G; Liu W
    Int J Pharm; 2012 Jul; 430(1-2):282-91. PubMed ID: 22484705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study.
    Ko YJ; Canil CM; Mukherjee SD; Winquist E; Elser C; Eisen A; Reaume MN; Zhang L; Sridhar SS
    Lancet Oncol; 2013 Jul; 14(8):769-76. PubMed ID: 23706985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration.
    Li R; Eun JS; Lee MK
    Arch Pharm Res; 2011 Feb; 34(2):331-7. PubMed ID: 21380818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of stabilized Paclitaxel nanocrystals: In-vitro and in-vivo efficacy studies.
    Sharma S; Verma A; Teja BV; Shukla P; Mishra PR
    Eur J Pharm Sci; 2015 Mar; 69():51-60. PubMed ID: 25559064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein nanoparticles as drug carriers in clinical medicine.
    Hawkins MJ; Soon-Shiong P; Desai N
    Adv Drug Deliv Rev; 2008 May; 60(8):876-85. PubMed ID: 18423779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel loaded PEG(5000)-DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation.
    Gill KK; Nazzal S; Kaddoumi A
    Eur J Pharm Biopharm; 2011 Oct; 79(2):276-84. PubMed ID: 21575719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replacing heme with paclitaxel to prepare drug-loaded globin nanoassembles for CD163 targeting.
    Meng Z; Yang X; Hu D; Wang K; Zhi F; Chen X; Gong G; Wu J; Hu Y
    J Pharm Sci; 2015 Mar; 104(3):1045-55. PubMed ID: 25640195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells.
    Wang C; Ho PC; Lim LY
    Int J Pharm; 2010 Nov; 400(1-2):201-10. PubMed ID: 20804835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy.
    Oh KS; Song JY; Cho SH; Lee BS; Kim SY; Kim K; Jeon H; Kwon IC; Yuk SH
    J Control Release; 2010 Dec; 148(3):344-50. PubMed ID: 20797418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and physicochemical characterization of a novel paclitaxel-loaded amphiphilic aminocalixarene nanoparticle platform for anticancer chemotherapy.
    Weeden C; Hartlieb KJ; Lim LY
    J Pharm Pharmacol; 2012 Oct; 64(10):1403-11. PubMed ID: 22943171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro cytotoxic activity of cationic paclitaxel nanoparticles on MDR-3T3 cells.
    Niu G; Castro CH; Nguyen N; Sullivan SM; Hughes JA
    J Drug Target; 2010 Jul; 18(6):468-76. PubMed ID: 20059301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An organic solvent-free technology for the fabrication of albumin-based paclitaxel nanoparticles for effective cancer therapy.
    Zhao Y; Cai C; Liu M; Zhao Y; Pei W; Chu X; Zhang H; Wang Z; Han J
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110394. PubMed ID: 31398618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of etoposide-loaded bovine serum albumin nanosuspensions for parenteral delivery.
    Wang Z; Li Z; Zhang D; Miao L; Huang G
    Drug Deliv; 2015 Jan; 22(1):79-85. PubMed ID: 24401038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: Formulation development and in vitro anticancer activity.
    Pulkkinen M; Pikkarainen J; Wirth T; Tarvainen T; Haapa-aho V; Korhonen H; Seppälä J; Järvinen K
    Eur J Pharm Biopharm; 2008 Sep; 70(1):66-74. PubMed ID: 18555675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
    Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
    J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.